Search

Author/Creator Voss, Söhnke

1. A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile. Issue 2 (8th January 2015)

Authors:
Heidenreich, Regina; Jasny, Edith; Kowalczyk, Aleksandra; Lutz, Johannes; Probst, Jochen; Baumhof, Patrick; Scheel, Birgit; Voss, Söhnke; Kallen, Karl‐Josef; Fotin‐Mleczek, Mariola
Journal:
International journal of cancer
Issue:
Volume 137:Issue 2(2015:Jul. 15)
Page Start:
372
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RNAdjuvant®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile. (4th November 2015)

Authors:
Heidenreich, Regina; Mehr, Keyvan Tadjalli; Noth, Janine; Koch, Sven; Hong, Henoch; Melber, Karl; Daehling, Angelika; Roos, Tilmann; Lutz, Johannes; Kowalczyk, Aleksandra; Baumhof, Patrick; Scheel, Birgit; Voss, Söhnke; Kallen, Karl-Josef; Fotin-Mleczek, Mariola; Gnad-Vogt, Ulrike
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. RNAdjuvant®, a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile. Issue 2 (December 2015)

Authors:
Heidenreich, Regina; Mehr, Keyvan; Noth, Janine; Koch, Sven; Hong, Henoch; Melber, Karl; Daehling, Angelika; Roos, Tilmann; Lutz, Johannes; Kowalczyk, Aleksandra; Baumhof, Patrick; Scheel, Birgit; Voss, Söhnke; Kallen, Karl-Josef; Fotin-Mleczek, Mariola; Gnad-Vogt, Ulrike
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗